Finance

Beta
Lists
HRMY:NASDAQ
Harmony Biosciences Holdings Inc
$32.20
-2.31%
(-0.76) 1D
$32.20
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRMY...
Open
$33.00
High
$33.20
Low
$32.06
Mkt. cap
1.86B
Avg. vol.
785.12K
Volume
462.30K
P/E ratio
12.94
52-wk high
$40.86
52-wk low
$25.52
EPS
$2.49
Beta
0.96
Shares outstanding
57.89M
No. of employees
293
Open
$33.00
High
$33.20
Low
$32.06
Mkt. cap
1.86B
Avg. vol.
785.12K
Volume
462.30K
P/E ratio
12.94
52-wk high
$40.86
52-wk low
$25.52
EPS
$2.49
Beta
0.96
Shares outstanding
57.89M
No. of employees
293
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to HRMY in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for HRMY in the last 3 months.
Highest
Current $32.20
$72.00 (+123.60%)
Average
$49.50 (+53.73%)
Lowest
$29.00 (-9.94%)
News stories
From sources across the web
About Harmony Biosciences Holdings Inc
CEO-
Employees293
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
200.49M
239.46M
243.78M
215.39M
Cost of goods sold
38.15M
59.65M
68.54M
44.51M
Cost of revenue
38.15M
59.65M
68.54M
44.51M
Research and development expenses
50.16M
54.96M
49.93M
69.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.00M
59.36M
86.74M
64.20M
Operating expense
114.16M
114.32M
136.67M
133.58M
Total operating expenses
152.31M
173.97M
205.22M
178.10M
Operating income
48.18M
65.49M
38.56M
37.29M
Other non operating income
-193.00K
-106.00K
-105.00K
-127.00K
EBT including unusual items
49.64M
67.49M
40.76M
39.69M
EBT excluding unusual items
49.64M
67.49M
40.76M
39.69M
Income tax expense
9.86M
16.62M
18.27M
7.20M
Effective tax rate
19.87%
24.63%
44.83%
18.14%
Other operating expenses
-
-
-
-
Net income
39.78M
50.86M
22.49M
32.49M
Net profit margin
19.84%
21.24%
9.22%
15.08%
Earnings per share
0.92
1.08
0.57
0.79
Interest and investment income
5.30M
5.73M
5.85M
5.76M
Interest expense
-3.65M
-3.62M
-3.55M
-3.23M
Net interest expenses
1.65M
2.11M
2.31M
2.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
54.15M
71.46M
45.99M
43.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more